Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation in drug-resistant epilepsy
2017-001019-35Phase 3Completed
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Calcirol in epilepsy (2 arms), sponsored by Centre Hospitalier Sainte-Anne. Primary endpoint: Percentage reduction in seizure frequency at 3 months. Started Jan 2018; status: completed.
02
Drugs
Calcirol
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2017-001019-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001019-35.